![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 487/04 | |
A61K 31/519 | |||
A61K 31/55 | |||
A61K 31/551 | |||
A61P 11/00 |
(11) | Number of the document | 3012258 |
(13) | Kind of document | T |
(96) | European patent application number | 15195216.5 |
Date of filing the European patent application | 2011-06-23 | |
(97) | Date of publication of the European application | 2016-04-27 |
(45) | Date of publication and mention of the grant of the patent | 2018-09-19 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
358122 P | 2010-06-24 | US |
(72) |
BABAOGLU, Kerim, US
BOOJAMRA, Constantine, G, US
EISENBERG, Eugene, J, US
HUI, Hon Chung, US
MACKMAN, Richard, L, US
PARRISH, Jay, P, US
SANGI, Michael, US
SAUNDERS, Oliver, L., US
SIEGEL, Dustin, US
SPERANDIO, David, US
YANG, Hai, US
|
(73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
(54) | PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVE AS AN ANTIVIRAL AGENT |
PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVE AS AN ANTIVIRAL AGENT |